Concentrics Research Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Concentrics Research's estimated annual revenue is currently $6M per year.(i)
  • Concentrics Research's estimated revenue per employee is $91,800

Employee Data

  • Concentrics Research has 65 Employees.(i)
  • Concentrics Research grew their employee count by 2% last year.

Concentrics Research's People

NameTitleEmail/Phone
1
President/CEOReveal Email/Phone
2
VP and General ManagerReveal Email/Phone
3
Director, Information Technology & SolutionsReveal Email/Phone
4
Director Finance and AdministrationReveal Email/Phone
5
Director, Finance and ContractsReveal Email/Phone
6
Manager, Project OperationsReveal Email/Phone
7
Manager Data ManagementReveal Email/Phone
8
Associate Project ManagerReveal Email/Phone
9
Associate Project ManagerReveal Email/Phone
10
Clinical Operations Project Manager, IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M140%N/AN/A
#2
$28.4M253-1%N/AN/A
#3
$3.9M48-8%N/AN/A
#4
$3.9M480%N/AN/A
#5
$83.4M654-6%N/AN/A
#6
$5M554%N/AN/A
#7
$6.1M6614%N/AN/A
#8
$6.7M7330%N/AN/A
#9
$7.8M7610%N/AN/A
#10
$3.2M3934%N/AN/A
Add Company

What Is Concentrics Research?

Concentrics Research is a unique CRO specializing in late-stage (Phase II-IV) and consumer healthcare research. We have a clinical division, a regulated healthcare market research division and we have a unique research site that allows us to conduct early iterative testing and single site testing for larger studies. With nearly 30 years of expertise in Rx-to-OTC Switch, clinical research and regulated healthcare marketing research, we create and execute custom research to meet your needs.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$6M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.8M6544%N/A
#2
$15.8M65-8%N/A
#3
$22.7M6544%N/A
#4
$15.8M65-12%N/A
#5
$8.8M6530%N/A